Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Enhanced expert advice for developers of AMR medicines

Written by | 7 Dec 2025

Companies developing medicines or vaccines targeting antimicrobial resistance (AMR) can now avail of improved scientific advice from the European Medicines Agency (EMA). The new approach brings together expertise… read more.

EMA teams up with influencers on weight loss drugs

Written by | 6 Dec 2025

The EU drug watchdog, the European Medicines Agency (EMA), has launched a partnership with social media influencers to promote the safe use of GLP-1 receptor agonists. The #HealthNotHype… read more.

Green light for new medicines at September 2025 meeting

Written by | 29 Sep 2025

The European Medicines Agency (EMA) has recommended 14 new medicines for approval at its September meeting. The key Committee on Human Medicinal Products (CHMP) reviews safety and efficacy… read more.

New guidance on pregnancy and breastfeeding during clinical trials

Written by | 28 Sep 2025

The European Medicines Agency (EMA) is working on guidelines for the inclusion of pregnant and breastfeeding individuals in clinical trials. The recommendations are designed to support better information… read more.

Watchdog warns of illegal weight loss medicines

Written by | 27 Sep 2025

Soaring demand for GLP-1 receptor agonists, commonly prescribed for diabetes and obesity, is driving a surge in the online sale of illegal medicines. The European Medicines Agency (EMA)… read more.

EU green light for 13 new medicines in June

Written by | 28 Jun 2025

The European Medicines Agency’s (EMA) key expert group has recommended 13 medicines for approval at its June 2025 meeting. The Committee on Medicinal Products for Human Use (CHMP)… read more.

EMA Annual Report: 114 new medicines in 2024

Written by | 27 Jun 2025

The European Medicines Agency (EMA) – the EU’s drug safety watchdog – approved 114 medicines last year, with 46 of these having a new active substance which had… read more.

New EU guidelines on pregnancy and breastfeeding in clinical trials

Written by | 26 Jun 2025

The European Medicines Agency (EMA) has launched a consultation on guidelines on how to include and retain pregnant and breastfeeding women in clinical trials. The goal is to… read more.

Green light for 16 new medicines in the EU

Written by | 22 May 2025

April was a bumper month for drug approvals in Europe, with sixteen new products recommended by the European Medicines Agency’s (EMA) key committee on human medicines. This almost… read more.

EU regulators warn of ‘vulnerabilities’ in supply of radiopharmaceuticals

Written by | 21 May 2025

Europe faces limited supplies of medicines containing radioisotopes which are used to diagnose or treat cancer, according to EU-level and national drug regulators. Experts say European countries should… read more.

EU renews mandate of drug watchdog chief

Written by | 20 May 2025

The European Medicines Agency (EMA) looks set to extend the contract of its Executive Director, Emer Cooke. The Agency’s Management Board unanimously recommended renewing her mandate at a… read more.

Green light for four new medicines in the EU

Written by | 9 Mar 2025

The European Medicines Agency (EMA) has recommended four new products for approval, and extended the use of sixteen other drugs. The decisions, which brings to 12 the total… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.